EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Healthy volunteer stem cell donors followed up 10 years after stimulation with biosimilar filgrastim

Jens Heyn, Susanne Bräuninger iD, Petra Becker, Niklas Stoeckmann, Christian Seidl, Sebastian Howe iD, Simon Daubert, Daniel Fürst, Hubert Schrezenmeier, Halvard Bonig iD

Transfusion · 2025-08 · 65 (8) · 1418-1426

DOI: 10.1111/trf.18317 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion, online erschienen am 09.07.2025. Verfasst von Jens Heyn und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hexal AG (a Sandoz Company), Holzkirchen, Germany. Hauptthemen laut MEDLINE: Filgrastim, Hematopoietic Stem Cell Mobilization, Biosimilar Pharmaceuticals, Granulocyte Colony-Stimulating Factor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: HEXAL AG (a Sandoz Company).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The application of granulocyte colony‐stimulating factors (G‐CSF) for mobilizing hematopoietic stem and progenitor cells in healthy donors is considered safe. However, only limited safety information is available about long‐term adverse events (AEs) in this setting. To determine the long‐term effect of health consequences to stem cell donors, 244 G‐CSF‐mobilized donors were tracked prospectively for 10 years. Study Design and Methods A total of 244 adult healthy unrelated stem cell donors who received at least one dose of Sandoz biosimilar filgrastim were enrolled in this prospective long‐term surveillance study. Safety, mental health, and physical health were followed up over a period of 10 years.

Results

Ninety‐five percent of the donors experience at least one AE during the stem mobilization period; beyond this period, the onset of the first AE was 3.86 [3.45–4.27] years in females and 4.02 [3.68–4.35] years in males. The risk of reporting an AE was significantly lower in the youngest tertile of donors, when compared to the oldest ( p = 0.026). Females were more likely to report AEs than males (0.40 vs. 0.21 AEs/year, rate ratio: 1.87 [CI: 1.32–2.64];

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FilgrastimHematopoietic Stem Cell MobilizationBiosimilar PharmaceuticalsGranulocyte Colony-Stimulating FactorTissue DonorsHumansFemaleMaleAdultMiddle AgedFollow-Up StudiesHealthy VolunteersProspective StudiesYoung Adult

Stichwörter der Autor:innen

donorsstem celltransfusion practices (oncology–hematology)transplantation

Substanzen

FilgrastimBiosimilar PharmaceuticalsGranulocyte Colony-Stimulating Factor

Autor:innen und Institutionen

  • Hexal AG (a Sandoz Company), Holzkirchen, Germany.
  • German Red Cross Blood Service Baden-Württemberg-Hessen, Institute Frankfurt, Frankfurt, Germany.
  • Institut für Klinische Transfusionsmedizin und Immungenetik Ulm (IKT), Ulm, Germany.
  • Institute of Transfusion Medicine, University of Ulm, Germany.
  • Institute for Transfusion Medicine and Immunohematology, Goethe University, Frankfurt, Germany.
  • Department of Medicine, Division of Hematology, University of Washington, Seattle, Washington, USA.

ORCID-Profile: Susanne Bräuninger, Sebastian Howe, Halvard Bonig

Förderung

  • HEXAL AG (a Sandoz Company)

Zitieren

APA

Heyn, J., Bräuninger, S., Becker, P., Stoeckmann, N., Seidl, C., Howe, S., Daubert, S., Fürst, D., Schrezenmeier, H., & Bonig, H. (2025). Healthy volunteer stem cell donors followed up 10 years after stimulation with biosimilar filgrastim. Transfusion, 65(8), 1418-1426. https://doi.org/10.1111/trf.18317

Vancouver

Heyn J, Bräuninger S, Becker P, Stoeckmann N, Seidl C, Howe S, et al. Healthy volunteer stem cell donors followed up 10 years after stimulation with biosimilar filgrastim. Transfusion. 2025;65(8):1418-1426. doi:10.1111/trf.18317

BibTeX
@article{Heyn2025,
  author = {Heyn, Jens and Bräuninger, Susanne and Becker, Petra and Stoeckmann, Niklas and Seidl, Christian and Howe, Sebastian and Daubert, Simon and Fürst, Daniel and Schrezenmeier, Hubert and Bonig, Halvard},
  title = {Healthy volunteer stem cell donors followed up 10 years after stimulation with biosimilar filgrastim},
  journal = {Transfusion},
  year = {2025},
  volume = {65},
  number = {8},
  pages = {1418--1426},
  doi = {10.1111/trf.18317}
}
Kostenlos starten →